GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

Diclegis is now the only FDA-approved drug for morning sickness. April 9, 2013— -- The U.S. Food and Drug Administration Monday approved Diclegis, a drug used to treat pregnant women for ...

Repurposed drugs could calm the immune system's response to nanomedicine. Story by Science X staff ... by using drugs already approved by the FDA for unrelated conditions. ...

The approval was in advance of the June 30 Prescription Drug User Fee Act action date. Verastem shares were flat at $6.69 prior to a trading halt for pending news. Write to Josh Beckerman at josh ...

Please provide your email address to receive an email when new articles are posted on . Large-data AI models may also be used to identify non-FDA-approved drugs for Parkinson’s disease. There is ...

UroGen Pharma shares surged after the company received Food and Drug Administration approval for bladder cancer drug Zusduri, previously known as UGN-102. The stock was recently up 36% to $9.96.

FDA extended aficamten's PDUFA date to Dec. 26, citing REMS review. No new clinical trials or data have been requested by the FDA. Get daily-updated rankings across momentum, growth, value, trends ...

Regeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory (R/R) multiple myeloma (MM). The regulatory body granted accelerated ...